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Highlights 
 Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth. 
 
 Dynasore attenuates canonical BMPR-Smad 1/5/8 signalling following BMP2 
treatment. 
 
 Dynamin-dependent endocytosis inhibition delays BMP2-activation of Smad 
signalling. 
 
 Dynasore inhibits BMP2-induced increases of SH-SY5Y neurite length and 
branching. 
 
 
Abstract 
Bone morphogenetic protein 2 (BMP2) is a neurotrophic factor which induces the growth of 
midbrain dopaminergic (DA) neurons in vitro and in vivo, and its neurotrophic effects have 
been shown to be dependent on activation of BMP receptors (BMPRs) and Smad 1/5/8 
signalling. However, the precise intracellular cascades that regulate BMP2-BMPR-Smad-
signalling-induced neurite growth remain unknown. Endocytosis has been shown to regulate 
Smad 1/5/8 signalling and differentiation induced by BMPs. However, these studies were 
carried out in non-neural cells. Indeed, there are scant reports regarding the role of 
endocytosis in BMP-Smad signalling in neurons. To address this, and to further characterise 
the mechanisms regulating the neurotrophic effects of BMP2, the present study examined the 
role of dynamin-dependent endocytosis in BMP2-induced Smad signalling and neurite 
growth in the SH-SY5Y neuronal cell line. The activation, temporal kinetics and magnitude 
of Smad 1/5/8 signalling induced by BMP2 were significantly attenuated by dynasore-
mediated inhibition of endocytosis in SH-SY5Y cells. Furthermore, BMP2-induced increases 
in neurite length and neurite branching in SH-SY5Y cells were significantly reduced 
following inhibition of dynamin-dependent endocytosis using dynasore. This study 
demonstrates that BMP2-induced Smad signalling and neurite growth is regulated by 
dynamin-dependent endocytosis in a model of human midbrain dopaminergic neurons.  
 
 
1 Abbreviations: BMP(s) - bone morphogenetic protein(s); BMPR(s) - BMP receptor(s); DA – 
dopaminergic; DIV – day(s) in vitro; PD - Parkinson’s disease ; VM - ventral midbrain. 
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Introduction 
Bone morphogenetic proteins (BMPs)1 are essential for the specification, differentiation and 
survival of a variety of neuronal populations during nervous system development [7]. BMPs 
have also emerged as regulators of the development of ventral midbrain (VM) dopaminergic 
(DA) neurons [9], a subpopulation of which progressively degenerates resulting in the motor 
                                                 
 
symptoms seen in Parkinson’s disease (PD) [15]. Indeed, BMP2 has been shown to have 
potent neurotrophic effects on VM DA neurons in vitro [6, 12, 23] and in vivo [4]. 
Additionally, using the SH-SY5Y neuronal cell line and embryonic rat VM primary cultures, 
we have shown that BMP2-induced DA neurite growth is dependent on canonical Smad 
signalling [6, 8]. In this pathway, BMPs bind to a complex of BMP receptor (BMPR) type I 
and type II. BMPRI subsequently phosphorylates Smad 1/5/8 transcription factors which bind 
to Smad4, and this phosphorylated Smad complex then translocates to the nucleus to 
modulate target gene expression [17, 24]. However, the precise molecular cascades that 
regulate BMP2-BMPR-Smad induced neurotrophic effects in VM DA neurons remain to be 
fully characterised.  
 Endocytosis of transmembrane receptors, such as BMPRs, regulates their availability 
at the cell membrane, and also attenuates signal transduction [25]. Receptor endocytosis 
occurs via either a clathrin-mediated or caveolae-mediated mechanism, both of which are 
dependent on dynamin [11, 14]. The internalized receptors are then recycled to the plasma 
membrane, degraded in lysosomes, or alternatively employ the endosome as a signalling 
platform, in which downstream components are presented for further activation [14]. BMPRs 
initiate distinct intracellular cascades depending on their endocytic route, membrane 
localization and mode of oligomerization [5]. Hartung et al. (2006) showed that the 
phosphorylation of Smad 1/5/8 by BMPRI is induced at the plasma membrane, while 
continuation of Smad signalling can occur, via endosomes, following endocytosis of the 
BMPRs in the C2C12 cell line [5]. Furthermore, inhibition of endocytosis has been shown to 
affect BMP-induced differentiation of osteoblasts [10, 22]. More recently, dynamin-
dependent endocytosis was shown to serve as a regulatory mechanism which fine-tunes Smad 
signalling [19]. Endocytosis therefore regulates canonical Smad signalling, and attenuates the 
differentiation-inducing effects of BMPs. However, at present, there are scant reports 
regarding the requirement for endocytosis in BMP-Smad signalling in neurons. To address 
this we assessed the contribution of dynamin-dependent endocytosis to BMP2-induced 
canonical Smad signalling and neurite outgrowth in the SH-SY5Y neuronal cell line.  
 
Materials and Methods 
Cell Culture 
SH-SY5Y cells were maintained in Dulbecco’s Modified Eagle Medium Nutrient Mixture F-
12 (Sigma), supplemented with 10% foetal calf serum (Sigma), 100nM L-Glutamine (Sigma), 
100U/ml Penicillin/Streptomycin (Sigma), in a humidified atmosphere containing 5% CO2 at 
37˚C. Where indicated, the cells were treated with 200 ng/ml of recombinant human BMP2 
(R&D Systems), and pre-treated (30 min prior to BMP2 application) with 40 μM of Dynasore 
(Sigma). Dynasore treatment was removed 4 h post BMP-application. To test Smad pathway 
activation, cells were treated for 0, 5, 30 or 60 min. For the neurite growth assay, cells were 
treated daily for 4 DIV and then labelled with the vital fluorescent dye calcein-AM (1:500; 
Invitrogen), by incubation at 37°C for 30 min. To assess the dynamin-dependent endocytosis 
inhibition efficiency of dynasore, SH-SY5Y cells were incubated in 30 μg/ml of Alexa594-
transferrin (Invitrogen), as previously described in a separate study [10]. 
 
Immunocytochemistry and Measurement of Cellular Morphology  
Immunocytochemistry and measurement of cellular morphology was performed as previously 
described [8]. Cultures were incubated in the following antibodies: BMPRII (1:200; R&D 
Systems), BMPRIb (1:200; R&D Systems), Smad 1/5/8 (1:200; Cell Signalling) or phopsho-
Smad 1/5/8 (1:200; Cell Signalling).  
 
Statistical Analysis 
Unpaired Student’s t-test or one-way ANOVA with a post hoc Tukey’s test or simple linear 
regression were performed and considered significant when p<0.05. 
 
Results 
Dynasore inhibits dynamin-dependent endocytosis in SH-SY5Y cells 
Firstly, immunocytochemistry was used to demonstrate that SH-SY5Y cells express both type 
I and type II BMPRs (Fig. 1a), as well as Smad 1/5/8 transcription factors (Fig. 1b), and can 
therefore initiate BMPR-Smad 1/5/8 signalling in response to BMP ligands. To determine if 
BMP-BMPR-Smad signalling is regulated by endocytosis in SH-SY5Y cells, the small 
molecule inhibitor dynasore, which specifically interferes with dynamin-dependent 
endocytosis [16], was used. To test the ability of dynasore to inhibit endocytosis, uptake of 
fluorescently-labelled transferrin was examined as a measurement of endocytosis [3]. Uptake 
of Alexa594-transferrin was inhibited following treatment with dynasore for 2 h (Fig. 2a-c). 
Dynasore treatment did not affect cell numbers compared to the control (Fig. 2d). These 
findings demonstrate that dynasore inhibits endocytosis in SH-SY5Y cells. 
 
The activation, temporal kinetics and magnitude of BMP2-induced Smad 1/5/8 
signalling in SH-SY5Y neuronal cells are regulated by dynamin-dependent endocytosis 
We next investigated the effect of dynasore on the activation, temporal kinetics and 
magnitude of Smad signalling induced by BMP2 in SH-SY5Y cells. Smad transcription 
factors are phosphorylated by type I and type II BMPRs and translocate to the nucleus, 
following activation of BMPR2 and BMPRIb by BMP2 (Fig. 3a). To examine this, cells were 
treated with BMP2 for 5, 30 and 60 min in the presence or absence of dynasore. Linear 
regression showed that BMP2 significantly increased p-Smad 1/5/8 levels over time (r2=0.71, 
p=0.0006) (Fig. 3b). However, 30 min pre-treatment with dynasore prior to the addition of 
BMP2 delayed the increase in phospho-Smad 1/5/8 levels. Significant increases in phospho-
Smad 1/5/8 levels were only detected after 30 min, rather than from 5 min onwards (Fig. 3d, 
e). Dynasore pre-treatment also significantly reduced the magnitude of BMP2-induced Smad 
signalling at 60 min (Fig. 3d, e). Taken together, these data demonstrate that activation of 
Smad signalling by BMP2 is regulated by dynamin-dependent endocytosis.  
 
BMP2-induced neurite growth of SH-SY5Y neuronal cells is significantly reduced by 
inhibition of dynamin-dependent endocytosis 
As BMP2 induces neurite growth via activation of BMPRs and Smad 1/5/8 transcription 
factors [8],  we next examined whether dynasore inhibited BMP-induced neurite growth. SH-
SY5Y cells were treated with BMP2 daily before being stained with the vital fluorescent dye 
calcein at 4 DIV, to allow visualisation of the neurites. To inhibit dynamin-dependent 
endocytosis, dynasore was added 30 min prior to the addition of BMP2. Dynasore treatment 
was maintained for the initial 4 h of BMP-stimulation, as longer-term dynasore treatment 
caused cell death (data not shown). Treatment with BMP2 resulted in a significant increase in 
the total length of neurites and axonal branching of the SH-SY5Y cells (Fig. 4). Similarly, 
SH-SY5Y cells treated with dynasore and BMP2 had significantly longer neurites when 
compared to the control (Fig. 4a, b). However, dynasore treatment significantly inhibited 
BMP2-induced axonal branching of SH-SY5Y cells (Fig. 4a, c). Furthermore, dynasore 
treatment significantly reduced the BMP2-induced increase in neurite length (Fig. 4a, b). 
Collectively, these findings show that dynamin-dependent endocytosis plays a role in BMP2-
induced neurite growth. 
 
Discussion 
BMP2 is a neurotrophic factor that regulates the neurite growth of VM DA neurons in vitro 
and in vivo [4, 6, 12, 23], and this effect has been shown to be dependent on BMPRIb 
activation of canonical Smad signalling [6, 8]. The present study aimed to build on these 
findings by investigating the contribution of endocytosis to the regulation of BMP2-induced 
Smad signalling and neurite growth in the human SH-SY5Y neuronal cell line, a widely used 
model of human midbrain DA neurons [2, 8, 26, 28]. 
 In order to achieve this, we inhibited dynamin-dependent endocytosis using the small 
molecule dynasore [16], an approach which was validated by measuring tranferrin uptake 
into the SH-SY5Y cells. We showed that Smad 1/5/8 signalling is still activated by BMP2 
when dynamin-dependent endocytosis is inhibited, a finding also observed in non-neuronal 
cells [10, 19]. However, dynasore treatment delayed the onset and reduced the magnitude of 
BMP2-induced Smad 1/5/8 signalling, which was shown by measuring the nuclear 
accumulation of phosphorylated Smad transcription factors. These data suggest that efficient 
phosphorylation and/or nuclear translocation of Smad 1/5/8, in response to BMP2, is 
regulated by dynamin-dependent endocytosis in SH-SY5Y neuronal cells. In support of these 
findings, Heining et al. (2011) showed that inhibition of endocytosis delays and reduces 
BMP2-induced Smad phosphorylation in the C2C12 cell line [10], while Paarmann et al. 
(2016) have shown that endocytosis serves as a regulatory mechanism which fine-tunes Smad 
signalling. Dynamin is crucial for fission of vesicles prior to their release from the plasma 
membrane [11, 14], which means that dynasore prevents the detachment of vesicles from 
membranes, leading to an accumulation of vesicles at the membrane. Such a disturbance to 
the localization of BMPRs may contribute to the delay and reduction in BMP2-induced 
phospho-Smad 1/5/8 nuclear accumulation observed in neuronal cells in this study. However, 
it is unclear whether the dynasore-mediated reduction in the nuclear accumulation of 
phospho-Smad 1/5/8 induced by BMP2 is due to a reduction in the levels of Smad 
phosphorylation at the membrane, or to a disruption of the translocation of phosphorylated 
Smads into the nucleus. To address this, the mechanisms which regulate BMP2-induced 
Smad-BMPR dissociation following phosphorylation, and the involvement of endocytosis in 
this process, need to be investigated.  
 We subsequently examined whether dynamin-dependent endocytosis regulates 
BMP2-induced neurite growth. Dynasore pre-treatment significantly inhibited BMP2-induced 
increases in the total length of neurites and axonal branching of SH-SY5Y cells. This result is 
not surprising, considering that inhibition of dynamin-dependent endocytosis affects the 
activation, kinetics and magnitude of BMP2-induced Smad 1/5/8 signalling, which is known 
to drive SH-SY5Y neurite growth [8]. Collectively, these data indicate a requirement for 
dynamin-dependent endocytosis in BMP2-induced neurite growth in SH-SY5Y cells. In 
support of the conclusion that endocytosis regulates BMP2-Smad-induced neuronal growth, 
BMP-Smad-induced synaptic growth at the Drosophila neuromuscular junction has been 
shown to be negatively regulated by a dynamin-dependent endocytosis inhibitor Nwk [18]. 
Moreover, BMP2-induced osteoblastic differentiation of C2C12 cells is also attenuated 
following early and short-term inhibition of dynamin-dependent endocytosis, using a 
dynasore treatment paradigm similar to this study [10]. Importantly, dynasore also regulates 
cholesterol in plasma membranes in a dynamin-independent manner [21], which should be 
considered when interpreting the findings of studies employing dynasore. Thus, dynamin-
dependent endocytosis appears to contribute to BMP-induced differentiation of both neuronal 
and non-neuronal cells. 
 BMP2 has been shown to be internalised by endocytosis in C2C12 cells [1, 13, 20, 
27]. Interestingly, endocytosis of BMP2-BMPR occurs immediately after formation of the 
ligand-receptor complex, with no further increase in BMP2-BMPR endocytosis occurring 
until after 30 min [1]. This is due to an initial BMPR saturation by the ligand, which is 
overcome following BMPR recycling to the plasma membrane [1]. Hartung et al. (2006) 
showed that the phosphorylation of Smad 1/5/8 by BMPRI is induced at the plasma 
membrane, while propagation of Smad signalling can occur following endocytosis of the 
BMPRs, where the endosome acts as a platform for continued BMPR-Smad signalling [5]. In 
this study, BMP2-induced Smad signalling levels increased from 5 to 30 min, and from 30 to 
60 min. Taking the findings of Hartung et al. (2006) and Alborzinia et al. (2013) into account, 
Smad phosphorylation at the plasma membrane may account for the levels observed at 5 min, 
while the significant increase at 30 min may be due to continuation/propagation of Smad 
signalling via endosomes following endocytosis of the BMP2-BMPR complex. The increase 
in BMP2-BMPR endocytosis after 30 min of treatment would then contribute to the further 
increase in BMP2-induced nuclear phosho-Smad 1/5/8 levels at 60 min. In this case, dual-
temporal inhibition of endocytosis by dynasore, first at 0 min (which delays Smad signalling) 
and then again at 30 min, causes the significant reduction in Smad signalling levels observed 
at 60 min following BMP2 treatment in SH-SY5Y cells. It would be worthwhile to examine 
whether this reduction in nuclear phosho-Smad 1/5/8 levels is sustained at later time-points. 
Based on the literature, we hypothesise that BMP2-induced Smad signalling levels would 
remain significantly inhibited at later time points, when BMP2 endocytosis continues to 
increase [1]. Indeed, Alborzinia et al. (2013) found that while saturation of BMPR binding 
limits the initial BMP2 uptake within the first hour of treatment, more binding sites 
subsequently appear at the plasma membrane, enabling an increase in BMP2 endocytosis 
over time [1]. In addition to this, dorsomorphin, a small molecular inhibitor of BMPRI [29], 
significantly reduces BMP2-BMPR endocytosis for up to 8 h [1]. Such a mechanism may 
have contributed to dorsomorphin-induced inhibition of BMP2-induced activation of the 
Smad 1/5/8 signalling pathway at 15 and 60 min in SH-SY5Y cells, which was observed in 
our previous study [8]. Furthermore, dorsomorphin also inhibited BMP2-induced neurite 
growth in SH-SY5Y cells [8]. This may have been due, at least in part, to dorsomorphin-
mediated short-term inhibition of BMP2-BMPR endocytosis [1]. In the current study, early 
and short-term inhibition of endocytosis (treatment with dynasore for initial 4 h) was 
sufficient to significantly inhibit the neurite-growth-promoting effects of BMP2.  
 Dynamin-dependent endocytosis thus appears to be required during the initial phase 
of BMP2 stimulation in order for this factor to exert its maximal effect on neurite outgrowth 
in SH-SY5Y cells. It is interesting that an initial, short-term, and dynasore-mediated 
inhibition of endocytosis results in a significant reduction in SH-SY5Y neurite growth at 4 
DIV following BMP2 treatment. We have previously shown that BMP2 induces significant 
increases in Smad signalling levels up to 2h after treatment in SH-SY5Y cells [8], and that 
these levels largely return to baseline ~6h-8h after treatment (unpublished observations). 
Furthermore, BMP-induced increases in neurite growth at 4 DIV is entirely dependent on 
Smad signalling (Smad4 siRNAs prevent this effect). Thus, this early, short-term and 
transient Smad activation window appears to be critical for longer-term neurite growth. It 
may be the case that interfering with a critical early window of Smad activation disrupts the 
long-term differentiation-inducing effects of BMPs that are observed at later time points. In 
support of this, BMP2-induced osteoblastic differentiation of C2C12 cells was also attenuated 
following an initial, early and short-term inhibition of dynamin-dependent endocytosis [10]. 
In the Heining et al. (2011) study, two classes of BMP2-induced genes, termed endocytosis-
dependent and endocytosis-independent genes, were also indentified. It may be the case that 
genes which contribute to BMP2-induced neurite growth are endocytosis-dependent. A 
characterisation of the molecular changes that are induced by BMPs in neurons, and their role 
in neurite growth, is an important question for further research.  
 The present study is the first to investigate endocytic regulation of BMP-BMPR-Smad 
signalling in mammalian neuronal cells. Given the essential physiological function of BMP-
Smad signalling during nervous system development [7], it would be interesting to 
investigate the contribution of endocytic regulation to BMP-Smad signalling-controlled 
nervous system developmental processes. Furthermore, dynamin-dependent endocytosis 
should also be investigated for its potential to enhance the DA neurotrophic effects of BMP-
BMPR-Smad signalling in preclinical models of PD. 
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Figure Legends 
Figure 1: SH-SY5Y cells express type I and type II BMP receptors and Smad 1/5/8 
transcription factors. Representative photomicrographs of SH-SY5Y cells 
immunocytochemically stained for (a) the BMPRs, BMPRIb and BMPRII, or (b) Smads 
1/5/8, and counterstained with DAPI (blue). Scale bar = 100 μm. 
 
Figure 2: Dynasore inhibits dynamin-dependent endocytosis in SH-SY5Y cells.  (a) Low 
power and (b) high power representative photomicrographs of Alexa594-transferrin 
immunofluorescence (red) in control and 40  dynasore-treated SH-SY5Y cells counter 
stained with DAPI (blue). (c) Relative immunofluorescence intensity of Alexa594-transferrin  
and (d) total cell number in cultures of SH-SY5Y cells treated with 40 μM dynasore or 
DMSO as a control (*** P < 0.001 vs. control; Student’s t-test; 20 fields for each group per 
experiment. N = 3). Data are expressed as mean ± SEM. Scale bar = 100 μm in (a) and 10 μm 
in (b) respectively. 
 
 
Figure 3: Dynasore impairs BMP2-induced Smad1/5/8 phosphorylation in SH-SY5Y 
cells. (a) Schematic representation showing that BMP2-activated BMPR signalling results in 
increased phosphorylation of Smad 1/5/8 (phospho-Smad 1/5/8), immunocytochemistry for 
which is shown in SH-SY5Y cells in the representative photomicrographs in (d). (b) Linear 
regression showing a significant correlation between time of exposure to BMP2 and nuclear 
phospho-Smad 1/5/8 levels. (c) Relative intensity of phospho-Smad immunofluorescence at 0 
(control), 5, 30, and 60 min  after treatment with BMP2 with or without 30 minute pre-
treatment with 40 μM dynasore (*** P < 0.001 vs. Cont (0 min);; $$$ P < 0.001; One-way 
ANOVA and post hoc Tukey’s test; 50 cells for each group per experiment. N = 3). Data are 
expressed as mean ± SEM. (d) Representative photomicrographs of BMP2-treated SH-SY5Y 
cells, with or without 40 μM dynasore treatment, and immunocytochemically stained for 
phospho-Smad 1/5/8 at 60 min. Scale bar = 100 μm. 
 
Figure 4: Dynasore impairs BMP2-induced neurite growth in SH-SY5Y cells. (a) 
Representative photomicrographs, (b) average neurite length and (c) number of axon 
branches per field in BMP2-treated SH-SY5Y cells with or without 40 μM dynasore, stained 
with the vital fluorescent dye Calcein after 4 DIV. Scale bar = 50 μm.  (* P < 0.05 and **** P 
< 0.0001 vs Cont; $$$ P < 0.0001; ANOVA with post-hoc Tukey’s test; 20 images analysed 
for each group per experiment; N = 3 experiments). Data are expressed as mean ± SEM.  
 
